Calendar Ascendis Pharma A/S

Equities

ASND

US04351P1012

Market Closed - Nasdaq 21:00:00 19/07/2024 BST 5-day change 1st Jan Change
135.2 USD -0.96% Intraday chart for Ascendis Pharma A/S -2.08% +7.35%

Chart calendar Ascendis Pharma A/S

b6963dc3fca1d8e41dd80e2d4ed7b74.PqNsUMEkzoi0LB7wpW3M9THK_IvjR2lJ3RZHvODx8t8.SME1ZYJ2pfDXWlCG8Tf4hgeas_zaJgw_u34v1dOzh4pLjl4oj3a-74wecQ~616059d0645af181e1b6738030ee56d9

Upcoming events on Ascendis Pharma A/S

28/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
01/04/2025 Q4 2024 Earnings Release (Projected)
20/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Ascendis Pharma A/S

11/06/2024 13:00 Goldman Sachs Global Healthcare Conference
03/06/2024 19:25 Endocrine Society Meeting
03/06/2024 17:00 Endocrine Society Meeting
02/06/2024 14:30 Endocrine Society Meeting
13/05/2024 11:40 European Endocrinology of Congress
12/05/2024 13:50 European Endocrinology of Congress
02/05/2024 21:30 Q1 2024 Earnings Call
02/05/2024 21:01 Q1 2024 Earnings Release
11/03/2024 18:00 Leerink Partners Global Biopharma Conference
13/02/2024 21:00 Oppenheimer Healthcare Life Sciences Conference
07/02/2024 21:30 Q4 2023 Earnings Call
07/02/2024 21:01 Q4 2023 Earnings Release
08/01/2024 17:00 JPMorgan Healthcare Conference
07/11/2023 21:30 Q3 2023 Earnings Call
07/11/2023 21:01 Q3 2023 Earnings Release
15/10/2023 American Association of Bone & Mineral Research Meeting - Poster No - #1114
20/09/2023 European Society for Paediatric Endocrinology Meeeting - Poster Number: LB-17
12/09/2023 17:55 Morgan Stanley Global Healthcare Conference
08/09/2023 13:00 Wells Fargo Healthcare Conference
07/09/2023 19:40 Citi BioPharma Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
13,4
12,4
8.01%
6,95
8,81
-21.06%
7,78
6,54
18.86%
51,2
45,5
12.57%
267
216
23.67%

423

EBITDA
Million EUR
Released
Forecast
Spread
-220
-214
-2.66%
-321
-301
-6.59%
-436
-436
-0.17%
-544
-535
-1.62%
-437
-506
13.77%

-197

EBIT
Million EUR
Released
Forecast
Spread
-227
-219
-3.4%
-331
-308
-7.41%
-452
-453
0.36%
-562
-556
-1.13%
-456
-516
11.77%

-209

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-218
-196
-11.37%
-419
-353
-18.58%
-384
-408
5.85%
-578
-543
-6.35%
-474
-471
-0.57%

-285

Net income
Million EUR
Released
Forecast
Spread
-218
-196
-11.43%
-419
-354
-18.23%
-384
-406
5.5%
-583
-530
-10.02%
-481
-493
2.26%

-299

EPS
EUR
Released
Forecast
Spread
-4,69
-4,18
-12.11%
-8,28
-6,98
-18.6%
-7,00
-7,49
6.52%
-10,4
-9,56
-8.82%
-8,55
-8,63
0.95%

-5,18

Announcement Date01/04/2010/03/2102/03/2216/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million EUR
Released
Forecast
Spread
6,83
4,47
52.64%
6,16
5,81
6.02%
15,3
8,81
73.57%
22,9
18,8
21.49%
33,6
21,5
56.04%
47,4
37,4
26.84%
48,0
48,0
0.09%
138
85,6
60.86%
95,9
79,9
20.07%

87,6


106


135


166


190

EBITDA
Million EUR
Released
Forecast
Spread
-124
-116
-6.56%
-138
-110
-24.56%
-140
-122
-14.88%



-139
-140
0.61%



-130
-128
-1.3%
-31,6
-40,0
20.92%
-44,7
-75,5
40.82%

-50,9


-42,2


-31,0







EBIT
Million EUR
Released
Forecast
Spread
-128
-117
-9.15%
-142
-128
-11.25%
-145
-143
-1.02%
-147
-144
-2.29%
-144
-150
4.34%
-141
-144
2.16%
-134
-135
0.6%
-36,6
-97,9
62.61%
-49,1
-88,3
44.32%

-67,9


-56,9


-35,2


-13,6


1,00

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-125
-118
-6.41%
-81,4
-129
36.95%
-169
-140
-20.97%
-202
-149
-35.55%
-110
-153
28.57%
-122
-141
13.32%
-162
-128
-26.16%
-81,1
-71,9
-12.84%
-129
-79,6
-61.49%

-71,0


-60,1


-37,9


8,00


9,00

Net income
Million EUR
Released
Forecast
Spread
-125
-115
-8.71%
-81,3
-120
31.99%
-169
-142
-19.17%
-207
-138
-50.04%
-111
-153
27.52%
-121
-144
15.61%
-162
-133
-21.99%
-86,9
-93,2
6.82%
-131
-83,1
-57.74%

-75,7


-65,2


-37,9


8,00


7,00

EPS
EUR
Released
Forecast
Spread
-2,21
-1,99
-10.85%
-1,46
-2,11
30.81%
-3,03
-2,53
-19.95%
-3,70
-2,48
-49.06%
-1,98
-2,71
26.97%
-2,16
-2,56
15.63%
-2,88
-2,35
-22.52%
-1,54
-1,57
2.15%
-2,30
-1,44
-59.53%

-1,33


-1,13


-0,67


0,15


0,13

Announcement Date11/05/2210/08/2202/11/2216/02/2327/04/2305/09/2307/11/2307/02/2402/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ASND Stock
  4. Calendar Ascendis Pharma A/S